Startup profile · funding coverage
Basata funding, valuation and investors
Specialty-specific AI agents automating healthcare admin — referrals, intake, scheduling, and follow-up.
Keep track of Basata
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series A
$21M · May 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$21M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series a · Phoenix, Arizona
Investors in latest funding
Lead: Basis Set Ventures
Other: Cowboy Ventures , PHX Ventures , Zenda Capital
Overview
Basata deploys specialty-specific AI agents that automate healthcare administrative workflows end-to-end — from faxed referrals to patient intake, AI voice scheduling, and EHR chart creation. Founded by CEO Kaled Alhanafi, the Phoenix company raised a $21M Series A in May 2026 led by Basis Set Ventures with participation from Cowboy Ventures, PHX Ventures, Zenda Capital, and Victoria Treyger, bringing total funding to $24.5M. Practices using Basata report processing 100% of incoming referrals the same day and unlocking roughly 50% more administrative capacity.
Why Basata is interesting
Basata processes faxes into booked appointments in minutes — 500K+ patients served with same-day referral processing for cardiology, urology, and other specialty groups.
Product & use cases
Basata's AI agents handle healthcare admin end-to-end — reading faxed referrals, creating EHR charts, calling patients via AI voice agents, and booking appointments in minutes instead of weeks.
- Autonomous referral processing from fax to scheduled appointment
- AI voice agents for patient intake and scheduling
- Specialty-specific workflows for cardiology, urology, gastroenterology, ophthalmology
Key facts
- Series A (May 2026): $21M led by Basis Set Ventures; Cowboy Ventures participated — $24.5M total raised (PR Newswire)
- 500K+ patients served; 100K in the past month alone (PR Newswire)
- Practices report 100% same-day referral processing and ~50% admin capacity gain (HIT Consultant)
- Specialties: cardiology, urology, gastroenterology, ophthalmology (company press)
Funding history (newest first)
Series A
2026-05 $21M- Basis Set Ventures (lead)
- Cowboy Ventures (participant)
- PHX Ventures (participant)
- Zenda Capital (participant)
Investors in our directory
Funds linked from Basata's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Specialty-tuned agents built alongside administrators in the trenches — replaces patchwork point solutions with one agentic operating system for practice operations.
Healthcare admin still runs on fax machines and phone trees despite AI progress elsewhere. Basata's specialty-specific agents target the $1T operational layer — competing with point solutions and manual workflows rather than a single dominant platform. Success depends on specialty workflow depth and EHR integration quality; Cowboy Ventures' Series A participation signals seed-stage validation of early traction metrics.
-
Notable Health adjacent
Healthcare automation; Basata focuses on specialty practice admin and fax-to-appointment loop.
-
Olive AI (wind-down) adjacent
Prior revenue-cycle automation entrant; Basata targets front-office ops not RCM.
-
Manual call centers + fax incumbent
Default for most specialty practices; Basata replaces hold music and manual data entry.
-
Epic scheduling modules incumbent
EHR-native scheduling; Basata adds AI layer on top of existing EHR workflows.
Notable stories
- CEO Kaled Alhanafi said patients still fight hold music and fax machines to get care in 2026 — Basata's mission is fully autonomous healthcare operations within a decade (PR Newswire).
- The founding team spent weeks in the trenches with administrative staff to tailor AI to specialty-specific clinical workflows (HIT Consultant).
- Basata's origin traces to the founder's mother's experience navigating healthcare access friction (HIT Consultant).
Industries
Related funding articles
Venture Capital Tracker pieces that cover Basata's financing or category context.
FAQs about Basata
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.